Aileron Therapeutics announced the promotion of Richard J. Wanstall to Chief Financial Officer and Treasurer, effective immediately. Mr. Wanstall has served as the Company's Vice President of Finance and Operations and principal accounting officer since 2018. Prior to joining the Aileron team in 2018, Mr. Wanstall served as Vice President of Finance at Moderna Therapeutics, Inc. Prior to Moderna, Mr. Wanstall served as Senior Vice President of Global Finance at Stream Global Services, Inc., from 2010 until 2014.

Previously, Mr. Wanstall also served in management roles in finance, accounting and SEC reporting for several technology and financial services companies.